Efficacy of Triple Therapy with Thymalfasin, Peginterferon alpha-2a, and Ribavirin for the Treatment of Hispanic Chronic Hepatitis C, Nonresponders by Poo JL et al. Journal title: Annals of Hepatology Authors: Hin Hin Ko, Eric Yoshida Subject(s):
Efficacy of triple therapy with thymalfasin, peginterferon α-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders Journal title: Annals of Hepatology Authors: Jorge Poo, Francisco Sánchez Ávila, David Kershenobich, Xochitl García Samper, Rocio Torres-Ibarra,... Subject(s):
Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial Journal title: Annals of Hepatology Authors: Mazhar Haque, Eric Yoshida Subject(s):
Current and future treatment options for HCV Journal title: Annals of Hepatology Authors: Bernd Kronenberger, Stefan Zeuzem Subject(s):
The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats Journal title: Annals of Hepatology Authors: Billur Canbakan, Hakan Akin, Gulgun Tahan, Orhan Tarcin, Fatih Eren, Ozlen Atug, Veysel Tahan... Subject(s):
Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents Journal title: Annals of Hepatology Authors: Salem Owayed, Jaber Al Ali, Wafa´a Al-Qabandi, Khaled Husain, Fuad Hasan Subject(s):
Treatment of HCV infection in patients with cirrhosis Journal title: Annals of Hepatology Authors: Angelo Alves de Mattos, Ângelo Zambam de Mattos Subject(s):
Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial Journal title: Annals of Hepatology Authors: Mario Pessôa, Hugo Cheinquer, Paulo Almeida, Giovanni Silva, Maria Lima, Raymundo Paraná, Marco Lace... Subject(s):
Genomic determinants of hepatitis C virus antiviral Journal title: Annals of Hepatology Authors: Mauricio Venegas, Javier Brahm, Rodrigo Villanueva Subject(s):
Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4 Journal title: Annals of Hepatology Authors: Juan Urquijo, Moisés Diago, Jaume Boadas, Ramón Planas, Ricard Solá, Javier Crespo, José Erdozaín, M... Subject(s):
Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir Journal title: Annals of Hepatology Authors: Vladimir Marquez-Azalgara, Trana Hussaini, Siegfried R. Erb, Eric M. Yoshida Subject(s):
EVALUATION OF HBV DNA LEVELS IN SALIVA IN SUBJECTS WITH DIFFERENT VIREMIA AS WELL AS DURING PEGINTERFERON α-2a THERAPY Journal title: Journal of IMAB - Annual Proceeding (Scientific Papers) Authors: Assya Krasteva, Vladimir Panov, Dejan Jelev, Krasimir Antonov, Aneta Ivanova, Zahariy Krastev Subject(s):
Do low- to middle-income countries need a biosimilar approval pathway based on a full comparability exercise? Journal title: Generics and Biosimilars Initiative Journal Authors: Armando A Genazzani, Nicola Magrini Subject(s):
Safety and Efficacy of Pegylated Interferon Alfa-2a for the Treatment of Hepatitis C in Patients with Major Thalassemia Journal title: Iranian Journal of Blood and Cancer Authors: Seyed-Moayed Alavian, Hassan Abolghasemi, Seyyed Mohammad Miri, Maryam Keshvari, Pegah Karimi Elizee... Subject(s):
Results of peginterferon alpha-2a treatment in patients with chronic hepatitis B in the Western part of Romania Journal title: RESEARCH AND CLINICAL MEDICINE Authors: Subject(s):